Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 11,694 shares at $117.77 ($1.4M) on 2024-06-17, disclosed to the SEC on 2024-06-20.
Scheduled sale ($1.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.18 | 7 | $806 | 0.1% |
| 2 | $117.16 | 2,212 | $259K | 18.9% |
| 3 | $117.16 | 2,212 | $259K | 18.9% |
| 4 | $117.77 | 475 | $56K | 4.1% |
| 5 | $117.77 | 475 | $56K | 4.1% |
| 6 | $116.75 | 3,007 |
| $351K |
| 25.7% |
| 7 | $116.75 | 3,007 | $351K | 25.7% |
| 8 | $117.25 | 299 | $35K | 2.6% |
| Total | $117.00 avg | 11,694 | $1.4M | 100% |
| Filing → |
| AMN | SELL | 2026-06-17 | $114K | — | Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |